Patients with IDH1-mutant astrocytomas have a better overall prognosis compared with those with IDH1-wildtype astrocytomas, even after controlling for histologic grade [1, 3]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).